CHLOROQUINE PHOSPHATE is a valuable drug used in the control of malaria and the treatment of amebiasis. The drug was developed in the United States during World War II for use as an antimalarial agent because of the shortage of quinine; the drug had been synthesized and studied as early as 1934 in Germany. Chloroquine is related chemically to quinine and, because of this similarity, has been suspected of being an ototoxic drug.1 It is currently being used for the treatment of malaria, amebiasis, rheumatoid arthritis, and for discoid and systemic lupus erythematosus. Side reactions such as skin eruption, bleaching of the hair, partial alopecia, retinopathy and blurred vision are not unusual.2 The drug is usually given by mouth, and is absorbed through the gastrointestinal tract when an acid medium is present. The medication can, however, be given intramuscularly. The usual dose is 0.5 gm/day for antimalarial
Matz GJ, Naunton RF. Ototoxicity of Chloroquine. Arch Otolaryngol. 1968;88(4):370–372. doi:10.1001/archotol.1968.00770010372008
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: